Literature DB >> 15067298

Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report.

Ercan Sivasli1, Deniz Dogru, Ayse Tana Aslan, Murat Yurdakok, Gulsevin Tekinalp.   

Abstract

Chylothorax, which is usually idiopathic, is the most common form of pleural effusion encountered in neonates. Herein we report a 2-week-old infant who had spontaneous chylothorax and was treated with octreotide. Neonatal chylothorax responded well to octreotide treatment, which appeared to shorten the duration of hospitalization. We conclude that octreotide should be considered in the treatment of neonatal chylothorax.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067298     DOI: 10.1038/sj.jp.7211052

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  4 in total

1.  Somatostatin treatment of spontaneous chylothorax in an extremely low birth weight infant.

Authors:  Ryszard Lauterbach; Bozena Sczaniecka; Justyna Koziol; Marta Knapczyk
Journal:  Eur J Pediatr       Date:  2004-12-21       Impact factor: 3.183

2.  Successful treatment of neonatal chylothorax with octreotide.

Authors:  Seyedeh Fatemeh Khatami; Pouya Parvaresh
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

3.  Congenital Chylothorax of the Newborn: A Systematic Analysis of Published Cases between 1990 and 2018.

Authors:  Bernhard Resch; Gülsen Sever Yildiz; Friedrich Reiterer
Journal:  Respiration       Date:  2021-09-01       Impact factor: 3.580

Review 4.  Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.

Authors:  Charles C Roehr; Andreas Jung; Hans Proquitté; Oliver Blankenstein; Hannes Hammer; Kokila Lakhoo; Roland R Wauer
Journal:  Intensive Care Med       Date:  2006-03-11       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.